Target intelligence / Profile preview

SMT3 suppressor of mif two 3 homolog 3 pseudogene

Molecular classification: Other, Pseudogene

Overview

The SMT3 suppressor of mif two 3 homolog 3 pseudogene (ENSG00000232089) is classified as a pseudogene in the human genome, sharing sequence similarity with the SMT3/SUMO3 family of small ubiquitin-like modifiers. Unlike the functional SMT3/SUMO3 proteins—which play roles in posttranslational modification and diverse cellular processes—this pseudogene is transcriptionally inactive and does not produce a functional protein product. As such, it is not considered a therapeutic target, biomarker, or relevant for drug development[3][5].

Other names: Small ubiquitin-like modifier 3 pseudogeneSUMO3 pseudogeneSMT3h3 pseudogeneSUMO-3 pseudogeneSMT3 suppressor of mif two 3 homolog 3 (S. cerevisiae), pseudogene[3][5]

Beyond the preview

Go deeper on SMT3 suppressor of mif two 3 homolog 3 pseudogene.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on SMT3 suppressor of mif two 3 homolog 3 pseudogene.

Explore the full profile